Tokyo, June 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061795) titled 'An examination of support strategies for coping with symptoms among community-dwelling individuals with Schizophrenia' on June 4.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - International University of Health and Welfare

Condition: Condition - Schizophrenia Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to examine how the coping abilities of people with schizophrenia who experience chronic auditory hallucinations and delusions and live in the community change before and after four sessions of short-term coping strategy enhancement therapy conducted by visiting nurses, and to determine whether these changes are associated with changes in psychiatric symptoms and quality of life (QOL). Furthermore, based on the results of this study, we will examine whether enhancing symptom coping abilities may lead to improved quality of life and relapse prevention, and we will explore appropriate approaches to support for people with schizophrenia living in the community through home-visit nursing. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - The research implementer, who is a visiting nurse, will implement the short-term coping strategy enhancement method for five people with chronic schizophrenia and positive symptoms such as hallucinations and delusions in the community. The intervention period is scheduled from June to early October 2026.

Eligibility: Age-lower limit - 18 years-old

Gender - Male and Female Key inclusion criteria - Eligible participants must meet the following criteria: 1. Be enrolled in the Keayakinomori Hospital's Keayaki Home Care Station between June 1, 2026 and early Octover, 2026. 2. Have a diagnosis of chronic schizophrenia with stable symptoms. 3. Have permission from their primary care physician to participate in the study. 4. Have given their informed consent to participate in the study in writing. 5. Be between the ages of 18 and 65 at the time of consent. Key exclusion criteria - The need for self-care and care for others is high, and the ability to understand and evaluate the severity of cognitive impairments is limited. Target Size - 5

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 06 Month 01 Day Anticipated trial start date - 2026 Year 06 Month 02 Day Last follow-up date - 2026 Year 10 Month 16 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070717

Disclaimer: Curated by HT Syndication.